(CELG:Consolidated Issue Listed on NASDAQ Global Select )
Thomas O. Daniel M.D.
|Age||Total Calculated Compensation||This person is connected to 28 board members in 2 different organizations across 6 different industries.|
See Board Relationships
Dr. Thomas O. Daniel, M.D., served as the President of Research & Early development of Celgene Corporation since December 2006 and also served as its Executive Vice President since February 15, 2012. Dr. Daniel has more than two decades of medical and pharmaceutical research experience and served as the Chief Scientific Officer at Ambrx Inc. since September 2003. He served as the Vice President of Research at Amgen Inc., where he served as Research Site Head of Amgen ...
86 Morris AvenuePhone: 908-673-9000
Summit, New Jersey 07901
Board Members Memberships*
University of Texas Southwestern Medical Center - Dallas
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Inge G. Thulin||Chairman, Chief Executive Officer and President|
|Erez Vigodman||Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee|
Teva Pharmaceutical Industries Limited
|Lars Rebien Sørensen||Chief Executive Officer|
Novo Nordisk A/S
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.5M||Compensation as of Fiscal Year 2013.|